Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
20
×
Tags
cancer
20
×
life sciences
national blog main
boston blog main
san francisco blog main
biotech
boston top stories
national top stories
san francisco top stories
clinical trials
indiana blog main
indiana top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
startups
deals
drugs
eli lilly
fda
investing
roche
cancer immunotherapy
merck
novartis
pfizer
What
drug
20
×
cancer
new
roundup
bio
research
fda
medicine
companies
approval
biotech
drugs
medicines
patients
targets
treatment
alzheimer’s
annual
approved
attention
blueprint
cells
designed
discovery
effective
fight
genetic
ipo
latest
lead
market
nash
news
plan
post
price
prices
raises
scientists
start
Language
unset
Current search:
cancer
×
drug
×
photo
×
@bgr.com
1 year ago
Nano-robot antibodies that fight cancer enter first human drug trial
@bgr.com
1 year ago
Doctors may have found a secret weapon to fight cancer: Viagra
@bgr.com
3 years ago
A drug for diarrhea can kill aggressive cancer cells
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@geekwire.com
4 years ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@extremetech.com
5 years ago
IBM Halts Sales of Watson AI For Drug Discovery and Research
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@extremetech.com
7 years ago
Microscopic magnets could revolutionize drug delivery